Phase IC Study of Safety and PK of SQ109 300mg Daily

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT01358162
First received: November 18, 2010
Last updated: May 10, 2013
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2011
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)